Philip Marcus

4.5k total citations · 2 hit papers
21 papers, 3.4k citations indexed

About

Philip Marcus is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Biomedical Engineering. According to data from OpenAlex, Philip Marcus has authored 21 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 2 papers in Biomedical Engineering. Recurrent topics in Philip Marcus's work include Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Respiratory and Cough-Related Research (6 papers). Philip Marcus is often cited by papers focused on Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Respiratory and Cough-Related Research (6 papers). Philip Marcus collaborates with scholars based in United States, India and Canada. Philip Marcus's co-authors include Robert A. Nathan, Mark Kosinski, Christine A. Sorkness, John Murray, Trudy Pendergraft, James T. Li, Michael Schätz, Michael Schatz, Priti Jhingran and Barbara P. Yawn and has published in prestigious journals such as CHEST Journal, The American Journal of Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Philip Marcus

20 papers receiving 3.3k citations

Hit Papers

Development of the asthma control test 2004 2026 2011 2018 2004 2006 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Marcus United States 12 2.9k 2.3k 518 350 190 21 3.4k
Trudy Pendergraft United States 8 2.8k 1.0× 2.2k 1.0× 502 1.0× 347 1.0× 194 1.0× 14 3.3k
E. F. Juniper Canada 18 2.2k 0.8× 1.7k 0.8× 704 1.4× 221 0.6× 234 1.2× 32 3.3k
Gordon R. Bloomberg United States 32 3.4k 1.2× 2.6k 1.2× 641 1.2× 292 0.8× 274 1.4× 61 4.5k
Henry Milgrom United States 29 3.0k 1.0× 2.1k 0.9× 1.2k 2.4× 229 0.7× 203 1.1× 93 4.3k
Andreï Malinovschi Sweden 30 2.2k 0.8× 2.0k 0.9× 585 1.1× 92 0.3× 172 0.9× 256 3.4k
Priti Jhingran United States 19 1.6k 0.6× 1.1k 0.5× 223 0.4× 192 0.5× 104 0.5× 30 2.7k
C. K. W. Lai Hong Kong 25 2.0k 0.7× 1.6k 0.7× 342 0.7× 139 0.4× 99 0.5× 48 2.4k
Rafaël Stelmach Brazil 25 1.6k 0.5× 1.8k 0.8× 159 0.3× 187 0.5× 163 0.9× 151 2.5k
John Kolbe New Zealand 37 1.2k 0.4× 2.6k 1.1× 109 0.2× 345 1.0× 178 0.9× 117 3.6k
Alan P. Baptist United States 25 1.2k 0.4× 783 0.3× 270 0.5× 419 1.2× 132 0.7× 103 2.2k

Countries citing papers authored by Philip Marcus

Since Specialization
Citations

This map shows the geographic impact of Philip Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Marcus more than expected).

Fields of papers citing papers by Philip Marcus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Marcus. The network helps show where Philip Marcus may publish in the future.

Co-authorship network of co-authors of Philip Marcus

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Marcus. A scholar is included among the top collaborators of Philip Marcus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Marcus. Philip Marcus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colice, Gene, Nancy K. Ostrom, David E. Geller, et al.. (2012). The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Annals of Allergy Asthma & Immunology. 108(3). 157–162.e1. 35 indexed citations
2.
Sethi, Sanjay, Donald A. Mahler, Philip Marcus, et al.. (2012). Inflammation in COPD: Implications for Management. The American Journal of Medicine. 125(12). 1162–1170. 85 indexed citations
3.
Cao, Jie, et al.. (2011). Effects of respiratory cycle and body position on quantitative pulmonary perfusion by MRI. Journal of Magnetic Resonance Imaging. 34(1). 225–230. 14 indexed citations
4.
Marcus, Philip & Sidney S. Braman. (2010). International Classification of Disease Coding for Obstructive Lung Disease. CHEST Journal. 138(1). 188–192. 12 indexed citations
6.
Bailey, William C., Frank C. Sciurba, Nicola A. Hanania, et al.. (2009). Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Primary Care Respiratory Journal. 18(3). 198–207. 13 indexed citations
7.
Marcus, Philip & Dean Dean. (2009). Budesonide Inhalation Suspension in Adults With Poorly Controlled Asthma or Chronic Obstructive Pulmonary Disease. 3 indexed citations
8.
Marcus, Philip, Renée J.G. Arnold, Sean Ekins, et al.. (2008). A retrospective randomized study of asthma control in the US: results of the CHARIOT study. Current Medical Research and Opinion. 24(12). 3443–3452. 27 indexed citations
9.
Marcus, Philip. (2006). Incorporating Anti-IgE (Omalizumab) Therapy Into Pulmonary Medicine Practice. CHEST Journal. 129(2). 466–474. 24 indexed citations
10.
Schatz, Michael, Christine A. Sorkness, James T. Li, et al.. (2006). Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. Journal of Allergy and Clinical Immunology. 117(3). 549–556. 933 indexed citations breakdown →
11.
Marcus, Philip, Edward Anthony Oppenheimer, Pankaj Patel, Laura M. Katz, & John Doyle. (2006). Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Annals of Allergy Asthma & Immunology. 96(5). 736–743. 10 indexed citations
12.
Marcus, Philip. (2005). The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease. Advances in Therapy. 22(4). 407–418. 12 indexed citations
13.
Marcus, Philip, et al.. (2005). Intrapatient symptom variability in adults and children with asthma: Results of a survey. Advances in Therapy. 22(5). 488–497. 2 indexed citations
14.
Nathan, R.A., Michael Schätz, Mark Kosinski, et al.. (2005). Performance of the Asthma Control Test™ (ACT) in adolescent patients with asthma. Journal of Allergy and Clinical Immunology. 115(2). S146–S146.
15.
Nathan, Robert A., Christine A. Sorkness, Mark Kosinski, et al.. (2004). Development of the asthma control test. Journal of Allergy and Clinical Immunology. 113(1). 59–65. 2184 indexed citations breakdown →
16.
Schatz, Michael, Christine A. Sorkness, John Murray, et al.. (2004). Specialist asthma care results in superior assessment of asthma control. Journal of Allergy and Clinical Immunology. 113(2). S253–S253. 2 indexed citations
17.
Sorkness, Christine A., Michael Schatz, R.A. Nathan, et al.. (2004). Assessing the relative contribution of the Asthma Control Test™ and spirometry in predicting asthma control. Journal of Allergy and Clinical Immunology. 113(2). S279–S279. 6 indexed citations
18.
Nathan, R.A., Christine A. Sorkness, Michael Schatz, et al.. (2003). Development of the asthma control test (ACT). Journal of Allergy and Clinical Immunology. 111(2). S214–S214. 8 indexed citations
19.
Marcus, Philip, et al.. (1997). Steroid therapy and H2-receptor antagonists: Pharmacoeconomic implications. Clinical Pharmacology & Therapeutics. 61(5). 503–508. 4 indexed citations
20.
Khan, Faroque A., et al.. (1980). Pulmonary Gangrene Occurring as a Complication of Pulmonary Tuberculosis. CHEST Journal. 77(1). 76–80. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026